India's traditional medicine systems — Ayurveda, Yoga & Naturopathy, Unani, Siddha, and Homeopathy (AYUSH) — received formal recognition in two landmark bilateral trade agreements finalised in late December 2025: the India-Oman Comprehensive Economic Partnership Agreement (CEPA) and the India-New Zealand Free Trade Agreement (FTA). Both agreements include dedicated annexures on health-related services and traditional medicine. The India-Oman CEPA is historically significant as the first international trade agreement in which any country has extended commitments on traditional medicine across all four modes of supply (cross-border trade, consumption abroad, commercial presence, and movement of natural persons). This creates a structured institutional framework for AYUSH services and products in Oman. The India-New Zealand FTA similarly includes dedicated cooperation provisions on AYUSH and Indian traditional knowledge, with explicit opportunities for Yoga instructors and other AYUSH practitioners to access the New Zealand market. India's AYUSH and herbal product exports grew 6.11 per cent from $649.2 million in 2023-24 to $688.89 million in 2024-25, demonstrating the sector's global traction. These recognitions are expected to accelerate AYUSH-related service exports, attract investment into herbal pharmaceuticals and wellness, and reinforce India's soft power through traditional knowledge diplomacy. For Rajasthan, which has clusters of Ayurvedic manufacturing and herbal cultivation (particularly in Barmer, Nagaur, and the Aravalli belt), such trade recognition presents concrete export-promotion possibilities.